It seems that doctors do not decide on vitamin D.
At the height of the global coronavirus outbreak, doctors had begun to observe a correlation between vitamin D deficiency and the severity of COVID-19 disease, with a study finding that 80% of patients who eventually went succumbing to the disease often also had few nutrients. which we derive mainly from sunlight.
However, these reports have been discussed by researchers who remain conservative when it comes to supplementation, and call for further research before consumers are encouraged to add vitamin D capsules to their diet.
Vitamin D deficiency has long been on the rise as humans spend less time working and being outdoors and working more in offices and online, and this is true now more than ever during the pandemic.
But a new report by Spanish researchers at Barcelona’s Hospital del Mar has added evidence to the pro-D field, particularly D3 or calcifediol, as a treatment for coronavirus patients. Their study of 930 COVID-19 patients found that those who received the supplement, rather than a placebo, saw a “reduced mortality of more than 60%,” the study authors wrote. These patients were also 80% less likely to require intensive care in the hospital.
Only 36 of the 551 patients taking calcifediol died from coronavirus. Meanwhile, the control group of 379 patients lost 57 due to the disease. In addition, only 5% of the cohort taking D3 was admitted to the ICU.
“This supports the conclusion of a previous pilot trial in Córdoba [Spain] in which treatment with calcifediol leads to a reduction of more than 50% in ICU admission in hospitalized COVID-19 patients ”, according to the full report.
The Social Science Research Network shared the results as previously published material, pending review by fellow medical researchers. This has not stopped some political leaders from praising uncontrolled findings, such as British lawmaker David Davis he screamed UK health officials to address the results of the study.
“Their findings are incredibly clear,” Said Deputy Davis on Sunday, in a tweet that 25,000 users liked on Twitter. “An 80% reduction in the need for an ICU and a 60% reduction in deaths, simply by giving a very cheap and very safe therapy.”
However, Yale researcher F. Perry Wilson has described the new report as “super sus” in a series of tweets fired Sunday.
“People, we have to talk about this vitamin D test. I have no involvement in this game – take vitamin D if you want, but this prepress is fantastic,” he wrote.
“If true, this would be one of the (if not THE) most effective treatments for COVID. But there are problems. . . ”Wilson suggested, noting that the type of“ randomized ”trial performed by doctors at Hospital del Mar was incompatible with the statistical model used to produce the results.
“This is a very basic thing: don’t call your study a randomized trial when it comes to a clustered randomized trial,” he added. “And fellow reviewers would have asked 100% for them to go back and redo the statistics.”